SGRY today
$26.58-$0.08 (-0.30%)close Nov 12, 2026Trend
DailyUptrend (confirmed)
4 hourStrong Bullish
1 hourLeaning Bearish
15 minSymmetric Triangle
5 minLeaning Bullish
Daily trend turns down below $12.97
Key levels
Resistance$28.62
Resistance$27.36
Support$26.16
Support$24.60
Latest news & SEC filings
AnalystTD Cowen keeps Hold rating on Surgery Partners, lifts target to $25
AnalystSurgery Partners cut to Neutral by Mizuho Securities
AnalystRBC Capital keeps Sector Perform on Surgery Partners, lifts target to $25
All SGRY news →About Surgery Partners
Surgery Partners runs a nationwide network of outpatient surgery centers and short-stay hospitals in the United States, along with physician practices offering several medical specialties. Its locations handle scheduled, non-emergency procedures such as orthopedic, pain, eye, digestive, and general surgeries. The company works with doctors, physician groups, and health systems, frequently sharing ownership of its facilities, and treats patients covered by commercial insurers, government plans, and out-of-pocket payment. It operates in roughly 30 states.
Based on the company's 10-K filed Mar 2, 2026.
Nasdaq · Healthcare
Surgery Partners, Inc. (SGRY)
What Is the Price Target for SGRY?
SEPT Low Target
$15.00
SEPT Mid Target
$23.50
SEPT High Target
$25.00
Analyst Consensus
$23.50
Is SGRY a Buy or Sell Right Now?
Thesis
- •Revenue growing 6.2% YoY with STABLE trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for SGRY.
Start Free Trial →Is SGRY Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$22.20
12
Moat Score
NONE
5/9
Piotroski Score
N/A
Altman Z-Score
What Is Smart Money Doing with SGRY?
Insider Signal
SELLING
0 buys / 11 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| HENDRIX BLAIR E | director 10% owner | Buy | 11,670 | $160K | Jun 5, 2026 |
| Deane John A | director | Buy | 11,670 | $160K | Jun 5, 2026 |
| Forese Laura L | director | Buy | 11,670 | $160K | Jun 5, 2026 |
| ADLERZ CLIFFORD G | director | Buy | 11,670 | $160K | Jun 5, 2026 |
| Dean Lloyd H | director | Buy | 11,670 | $160K | Jun 5, 2026 |
| DeLuca Teresa | director | Buy | 11,670 | $160K | Jun 5, 2026 |
| TURNER BRENT | director | Buy | 11,670 | $160K | Jun 5, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →SGRY Growth Story
Revenue YoY
6.2%
3yr Revenue CAGR
9.2%
EPS Growth YoY
54.14%
FCF Growth YoY
-6.7%
Revenue Trend
STABLE
Dark Pool Trades for SGRY
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for SGRY, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:10 | $26.58 | 1,647 | $$44K | BUY |
| 21:00:10 | $26.58 | 1,492 | $$40K | BUY |
| 21:00:10 | $26.58 | 4,099 | $$109K | BUY |
| 21:00:06 | $26.58 | 7,914 | $$210K | BUY |
| 20:59:59 | $26.59 | 1,300 | $$35K | SELL |
5 dark pool trades shown · $$437K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for SGRY
PREVIEWSEPT Investing provides real-time options flow tracking for SGRY, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $27.5 | Nov 20 | 8 | $$45 | 3 | SWEEP |
| CALL | $27.5 | Nov 20 | 8 | $$15 | 1 | SWEEP |
| CALL | $27.5 | Nov 20 | 8 | $$15 | 1 | SWEEP |
| CALL | $27.5 | Nov 20 | 8 | $$15 | 1 | SWEEP |
| CALL | $27.5 | Nov 20 | 8 | $$180 | 12 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Surgery Partners, Inc. (SGRY) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →SGRY — frequently asked questions
What is SGRY stock price today?
Surgery Partners, Inc. (SGRY) is at $26.58, down 0.30% (-$0.08) at the Nov 12, 2026 close.
Why is SGRY stock moving today?
Latest SGRY news — Nov 11, 2026: TD Cowen keeps Hold rating on Surgery Partners, lifts target to $25 · Nov 11, 2026: Surgery Partners cut to Neutral by Mizuho Securities
Why did SGRY stock move on Oct 26, 2026?
Surgery Partners (SGRY) shares closed at $23.25, up 0.93% on heavy volume of 57.5 million shares, as the company agreed to be taken private by HealthSpan Partners in an all-cash deal valued at approximately $5.7 billion. The transaction removes SGRY from public trading, and the bullish merger news is the dominant catalyst for the stock.
What is the SGRY price target?
The average analyst price target for SGRY is $23.50, ranging from $15 to $25, based on 5 analysts. Latest: TD Cowen maintains on Nov 11, 2026.
What do analysts rate SGRY?
Analyst ratings for SGRY: 0 Buy, 6 Hold, 4 Sell — consensus Hold.
Did SGRY beat earnings?
SGRY last reported on Nov 9, 2026: EPS $0.16 vs $0.12 expected — a beat of 33.3%.
Does SGRY pay a dividend?
SGRY does not currently pay a dividend.
How much debt does SGRY have?
Surgery Partners, Inc. reported $3.6B of debt and $217M of cash (Jun 30, 2026).
What are SGRY support and resistance levels?
Support: $26.16, $24.60, $23.37. Resistance: $27.36, $28.62, $29.94.
What are insiders doing with SGRY?
Insider activity: SELLING, 0 buys and 11 sells in the last 90 days.
What is the latest news on SGRY?
Nov 11, 2026: TD Cowen keeps Hold rating on Surgery Partners, lifts target to $25 · Nov 11, 2026: Surgery Partners cut to Neutral by Mizuho Securities · Nov 10, 2026: RBC Capital keeps Sector Perform on Surgery Partners, lifts target to $25